Sanos Group will close a gap in the market gap with new Clinical Trial Supply unit

Necessary, correct, and timely delivery of drugs and equipment is an important part of clinical studies, which is carried out under increasing demands and complexity. Sanos Group will deliver added value to both pharma and biotech customers with a simple and efficient business model, in which all necessary skills are gathered, and where customers experience that all aspects of clinical development can be lifted.

"We can see that there has been a lack of a local player with global reach in the market, where, for example, Danish companies within biotech can now get the necessary attention and obtain better service than if they have to partner up with international giants for contract manufacturing and logistics services. We want to be both faster and more service-oriented,” says Jeppe Ragnar Andersen, Group CEO of Sanos Group.

The demand for reliable and timely deliveries of drugs and distribution of devices for clinical studies is increasing in an uncertain world. But several decentralized clinical studies with widespread use of digitization also significantly shortens the study timeline and set new requirements to avoid long and expensive delays.

"Sanos Supply will deliver clinical trial supply services in line with the way we conduct clinical studies with an efficient process and always within the agreed budget", says Jeppe Ragnar Andersen.

Qualified production unit approved by the Danish Medicines Agency

With the establishment of Sanos Supply, the Sanos Group adds a GMP-certified production unit approved by the Danish Medicines Agency to their portfolio of clinical services. The day-to-day operations of Sanos Supply will be led by Jonas Dyndegaard and Antony Pham, who for several years have provided consulting services in the area and will continue to do so under the Sanos Group.

"We are very much looking forward to delivering quality solutions, shortening the long production times, and solving supply chain challenges through interdisciplinary collaboration with the operational team in the Sanos Group, but also to a great extent through close collaboration with strategic partners and suppliers," says Antony Pham, CEO of Sanos Supply.

Sanos Supply is already supplying a global phase II study with 13 clinics, 5 countries, and over 400 participants within osteoarthritis, just as the company supplies commercial customers such as more pharmacies.

Sanos Supply is located in Hørsholm, from where they efficiently produce and distribute pharmaceuticals for studies in the EU, USA, and countries in the Asia and Pacific region via strategic partners and qualified depots. Sanos Supply has a unique position in the market with innovative solutions such as Sanos Supply EXPEDITE, where the customer gets fast-track without compromising on quality, and Sanos Supply BOX, a sustainable and generic packaging material that molds to the product.

Further information can be obtained from:

Group CEO Jeppe Ragnar Andersen, Sanos Group, +45 7370 8223, jra@sanos.com

CEO Antony Pham, Sanos Supply, +45 8198 6869, ap@sanossupply.com

About Sanos Group

Sanos Group is a leading provider of specialized services for clinical studies in the global pharmaceutical and biotech industry. The group consists of around 100 employees, primarily located in Denmark and the USA, but also elsewhere in Europe, as well as in Hong Kong, having their headquater in Herlev. In addition to Sanos Supply, the group also includes Sanos Clinic, which consists of 4 private research clinics in Denmark, including a phase 1 unit that focuses exclusively on clinical studies, the global full-service CRO, NBCD, and Studies&Me, which consists of a digital recruitment platform and a CRO with a dermatological and DCT focus.